Related references
Note: Only part of the references are listed.Converging Indications of Aldosterone Antagonists (Spironolactone and Eplerenone): A Narrative Review of Safety Profiles
Mohammed I. Danjuma et al.
CURRENT HYPERTENSION REPORTS (2014)
Deletion of bone-marrow-derived receptor for AGEs (RAGE) improves renal function in an experimental mouse model of diabetes
Greg Tesch et al.
DIABETOLOGIA (2014)
Myeloid Mineralocorticoid Receptor Activation Contributes to Progressive Kidney Disease
Louis L. Huang et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Aldosterone stimulates fibronectin synthesis in renal fibroblasts through mineralocorticoid receptor-dependent and independent mechanisms
Dong Chen et al.
GENE (2013)
PF-03882845, a non-steroidal mineralocorticoid receptor antagonist, prevents renal injury with reduced risk of hyperkalemia in an animal model of nephropathy
Stephen Orena et al.
FRONTIERS IN PHARMACOLOGY (2013)
Mineralocorticoid Receptor-Associated Hypertension and Its Organ Damage: Clinical Relevance for Resistant Hypertension
Hirotaka Shibata et al.
AMERICAN JOURNAL OF HYPERTENSION (2012)
Discovery of BAY 94-8862: A Nonsteroidal Antagonist of the Mineralocorticoid Receptor for the Treatment of Cardiorenal Diseases
Lars Baerfacker et al.
CHEMMEDCHEM (2012)
Long-term mineralocorticoid receptor blockade ameliorates progression of experimental diabetic renal disease
Michael Lian et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2012)
Aldosterone Induces Kidney Fibroblast Proliferation via Activation of Growth Factor Receptors and PI3K/MAPK Signalling
L. L. Huang et al.
NEPHRON EXPERIMENTAL NEPHROLOGY (2012)
Antihypertensive and Cardiorenal Protective Effects of SM-368229, a Novel Mineralocorticoid Receptor Antagonist, in Aldosterone/Salt-Treated Rats
Tetsuro Nariai et al.
PHARMACOLOGY (2012)
Mineralocorticoid receptor-mediated DNA damage in kidneys of DOCA-salt hypertensive rats
Nicole Schupp et al.
FASEB JOURNAL (2011)
Mineralocorticoid receptor activation and blockade: an emerging paradigm in chronic kidney disease
Jean-Philippe Bertocchio et al.
KIDNEY INTERNATIONAL (2011)
Moderate Antiproteinuric Effect of Add-On Aldosterone Blockade with Eplerenone in Non-Diabetic Chronic Kidney Disease. A Randomized Cross-Over Study
Lene Boesby et al.
PLOS ONE (2011)
Intensive Versus Conventional Therapy to Slow the Progression of Idiopathic Glomerular Diseases
Stefano Bianchi et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2010)
A New Mode of Mineralocorticoid Receptor Antagonism by a Potent and Selective Nonsteroidal Molecule
Jerome Fagart et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Aldosterone-induced mesangial cell proliferation is mediated by EGF receptor transactivation
Songming Huang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2009)
Aldosterone induces myofibroblastic transdifferentiation and collagen gene expression through the Rho-kinase dependent signaling pathway in rat mesangial cells
Suwarni Diah et al.
EXPERIMENTAL CELL RESEARCH (2008)
The role of aldosterone blockade in murine lupus nephritis
Seetha U. Monrad et al.
ARTHRITIS RESEARCH & THERAPY (2008)
Mineralocorticoid receptor antagonist reduces renal injury in rodent models of types 1 and 2 diabetes mellitus
Christine Guo et al.
ENDOCRINOLOGY (2006)
Aldosterone promotes fibronectin production through a Smad2-dependent TGF-β1 pathway in mesangial cells
Lingyun Lai et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Spironolactone prevents diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats
Sang-Youb Han et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Aldosterone stimulates collagen gene expression and synthesis via activation of ERK1/2 in rat renal fibroblasts
Y Nagai et al.
HYPERTENSION (2005)
A nuclear receptor atlas: Macrophage activation
GD Barish et al.
MOLECULAR ENDOCRINOLOGY (2005)
Beneficial effects of adding spironolactone to recommended antihypertensive treatment in diabetic nephropathy - A randomized, double-masked, cross-over study
K Rossing et al.
DIABETES CARE (2005)
Aldosterone/salt induces renal inflammation and fibrosis in hypertensive rats
ER Blasi et al.
KIDNEY INTERNATIONAL (2003)
Share Paper
